Oncogenic Osteomalacia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-04-08
Clinical Trial Update: BGJ398 for the Treatment of Tumor-Induced Osteomalacia [Phase 2]
Phase 2 trial of BGJ398 for tumor-induced osteomalacia was terminated; results posted in 2021.